Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luong Nguyen

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Ebiomedicine|January 19, 2022
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I studyOdile Launay, Cécile Artaud, Marie Lachâtre, et al.
Communications Medicine|January 18, 2025
Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variantsOdile Launay, Rachna Gupta, Tifany Machabert, et al.
Vaccine|August 23, 2025
Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART studyLiem Binh Luong Nguyen, Lyvia Magloire, Alexis François, et al.
La Revue De Medecine Interne|February 3, 2016
Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)B Bienvenu, K H Ly, M Lambert, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 proteaseNathaniel T Kenton, Haim Barr, Artem Cherepakha, et al.
Influenza and Other Respiratory Viruses|November 25, 2025
COVID-19 Vaccine Effectiveness Against Hospitalization in Older Adults, VEBIS Hospital Network, Europe, September 2024-May 2025Madelyn Rojas-Castro, Nuno Verdasca, Susana Monge, et al.
BMC Medicine|November 4, 2025
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24Angela Mary Catherine Rose, Nathalie Nicolay, Clara Mazagatos, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Ebiomedicine|January 19, 2022
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I studyOdile Launay, Cécile Artaud, Marie Lachâtre, et al.
Communications Medicine|January 18, 2025
Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variantsOdile Launay, Rachna Gupta, Tifany Machabert, et al.
Vaccine|August 23, 2025
Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART studyLiem Binh Luong Nguyen, Lyvia Magloire, Alexis François, et al.
La Revue De Medecine Interne|February 3, 2016
Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)B Bienvenu, K H Ly, M Lambert, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 proteaseNathaniel T Kenton, Haim Barr, Artem Cherepakha, et al.
Influenza and Other Respiratory Viruses|November 25, 2025
COVID-19 Vaccine Effectiveness Against Hospitalization in Older Adults, VEBIS Hospital Network, Europe, September 2024-May 2025Madelyn Rojas-Castro, Nuno Verdasca, Susana Monge, et al.
BMC Medicine|November 4, 2025
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24Angela Mary Catherine Rose, Nathalie Nicolay, Clara Mazagatos, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Pageof 15